Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: a post-hoc analysis of patients taking 1 - 3 mg/24 h for up to 5 years.
about
P2860
Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: a post-hoc analysis of patients taking 1 - 3 mg/24 h for up to 5 years.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Safety and efficacy of rotigot ...... - 3 mg/24 h for up to 5 years.
@en
Safety and efficacy of rotigot ...... - 3 mg/24 h for up to 5 years.
@nl
type
label
Safety and efficacy of rotigot ...... - 3 mg/24 h for up to 5 years.
@en
Safety and efficacy of rotigot ...... - 3 mg/24 h for up to 5 years.
@nl
prefLabel
Safety and efficacy of rotigot ...... - 3 mg/24 h for up to 5 years.
@en
Safety and efficacy of rotigot ...... - 3 mg/24 h for up to 5 years.
@nl
P2093
P2860
P1476
Safety and efficacy of rotigot ...... - 3 mg/24 h for up to 5 years.
@en
P2093
Andreas Fichtner
Diego García-Borreguero
Elisabeth Dohin
Erwin Schollmayer
Lars Bauer
P2860
P356
10.1517/14656566.2013.758251
P407
P577
2012-12-21T00:00:00Z